Sustained release drug formulations containing a carrier peptide
CA 2474613 A1 · Owner: Societe De Conseils De Recherches Et D'Applications Scientifiques, S.A.S. · Inventors: Cherif-Cheikh, Roland; Moreau, Jacques-Pierre
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention features a method of administering one or more therapeutic agents to a patient and delivering said agent or agents continuously over an extended period of time, said method comprising: obtaining a pharmaceutical composition including a peptide carrier one or more therapeutic agents, and , up to 30 percent by weight, of a pharmaceutically acceptable soluble, monomeric carrier; and parenterally administering said pharmaceutical composition to a subject by injection, wherein said composition automatically forms a gel after interaction with the patient's bodily fluids and releases said peptide carrier and said agent or agents continuously within the patient over an extended …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 4, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 4, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 4, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.